@article{1fb134d578634799a2f4c8577e6a511d,
title = "Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation [3]",
author = "Jan Volavka and Nolan, {Karen A.} and Linda Kline and Pal Czobor and Leslie Citrome and Brian Sheitman and Lindenmayer, {Jean Pierre} and Joseph McEvoy and Lieberman, {Jeffrey A.}",
note = "Funding Information: NIMH grant (R10 MH53550) provided the principal support for this project. Additional support was provided by the UNC-Mental Health and Neuroscience Clinical Research Center (MH MH33127) and the Foundation of Hope, Raleigh North Carolina. We thank Janssen Pharmaceutica Research Foundation, Eli Lilly and Company, Novartis Pharmaceuticals Corporation, and Merck and Co. for their generous gifts of medications. Eli Lilly and Company contributed supplemental funding that covered approximately 18% of the total cost of the study. However, overall experimental design, data acquisition, statistical analyses, and interpretation of the results were implemented without any input from any of the pharmaceutical companies.",
year = "2005",
month = jul,
day = "1",
doi = "10.1016/j.schres.2004.11.007",
language = "English (US)",
volume = "76",
pages = "127--129",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "1",
}
